Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81–95 peptide show effective antitumor activity against ovarian carcinomaXiaoyan Zhang, Congjian Xu, Jun Chen et al.|International Journal of Pharmaceutics|2013Cited by 38
Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cellsYi Yu, Congjian Xu|Journal of Hematology & Oncology|2014Cited by 27
Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cellsYi Yu, Congjian Xu|Journal of Ovarian Research|2014Cited by 23
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cellsYi Yu, Congjian Xu|Journal of Experimental & Clinical Cancer Research|2014Cited by 22
An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancerJing Xu, Congjian Xu|Cancer Chemotherapy and Pharmacology|2022Cited by 16